The status of 2-year-old children who had received sulfisoxazole in the neonatal period after premature birth.
D001921:Brain; D001927:Brain Diseases; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases; D019102:Infant, Very Low Birth Weight; D011247:Pregnancy; D047928:Premature Birth; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013444:Sulfisoxazole; D013449:Sulfonamides / Q000627:therapeutic use*
D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D013444:Sulfisoxazole
BRAIN/diseases; INFANT, PREMATURE/diseases; SULFONAMIDES/therapeutic use